Clinical efficacy and safety of prolonged versus intermittent administration of antipseudomonal beta-lactam antibiotics in adults with severe acute infections: A meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Clinical efficacy and safety of prolonged versus intermittent administration of antipseudomonal beta-lactam antibiotics in adults with severe acute infections: A meta-analysis of randomized controlled trials

Published:2023-09 Issue:9 Volume:29 Page:855-862
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Kıran Pınar^ORCID,Nadir Yasemin^ORCID,Gencer Serap^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Reference45 articles.

1. Pharmacokinetic/Pharmacodynamic Considerations of beta-lactam antibiotics in adult critically ill patients;Masich;Curr Infect Dis Rep,2018

2. Pharmacokinetic optimization of β-lactams for the treatment of ventilator-associated pneumonia;Drusano;Eur Respir Rev,2007

3. Application of antimicrobial pharmacodynamic concepts into clinical practice: focus on beta-lactam antibiotics: insights from the Society of Infectious Diseases Pharmacists;Lodise;Pharmacotherapy,2006

4. Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients: protocol for a randomised, multicentre, open-label, superiority clinical trial (BEATLE);Laporte-Amargos;Trials,2020

5. Duration of exposure to antipseudomonal β-lactam antibiotics in the critically ill and development of new resistance;Teshome;Pharmacotherapy,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prolonged vs intermittent intravenous infusion of β-lactam antibiotics for patients with sepsis: a systematic review of randomized clinical trials with meta-analysis and trial sequential analysis;Annals of Intensive Care;2023-12-05

2. Continuous infusion of cefiderocol in a critically ill patient with continuous venovenous haemofiltration;British Journal of Clinical Pharmacology;2023-09-20